GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (NYSE:KVUE) » Definitions » Ending Cash Position

Kenvue (Kenvue) Ending Cash Position : $1,155 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Kenvue Ending Cash Position?

Kenvue's Ending Cash Position for the quarter that ended in Mar. 2024 was $1,155 Mil.

Kenvue's quarterly Ending Cash Position increased from Sep. 2023 ($1,062 Mil) to Dec. 2023 ($1,382 Mil) but then declined from Dec. 2023 ($1,382 Mil) to Mar. 2024 ($1,155 Mil).

Kenvue's annual Ending Cash Position increased from Dec. 2021 ($740 Mil) to Dec. 2022 ($1,231 Mil) and increased from Dec. 2022 ($1,231 Mil) to Dec. 2023 ($1,382 Mil).


Kenvue Ending Cash Position Historical Data

The historical data trend for Kenvue's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kenvue Ending Cash Position Chart

Kenvue Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
752.00 618.00 740.00 1,231.00 1,382.00

Kenvue Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,386.00 1,231.00 1,062.00 1,382.00 1,155.00

Kenvue Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Kenvue's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1231+151
=1,382

Kenvue's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1382+-227
=1,155


Kenvue Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Kenvue's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Kenvue (Kenvue) Business Description

Traded in Other Exchanges
Address
199 Grandview Road, Skillman, NJ, USA, 08558
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Executives
Allison Richard E Jr director 30 FRANK LLOYD WRIGHT DR, ANN ARBOR MI 48105
Seemantini Godbole director 1000 LOWE'S BOULEVARD, MOORESVILLE NC 28117
Bing Xie officer: Group President, Asia Pacific 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Donna Lorenson officer: Chief Corp Affairs Officer 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Matthew Orlando officer: General Counsel 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Luani Alvarado officer: Chief People Officer 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Jan Meurer officer: Chief Growth Officer 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Carlton Lawson officer: Group President, EMEA 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Caroline Tillett officer: Chief Scientific Officer 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Bernardo Tavares officer: Chief Tech & Data Officer 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Tamara Franklin director 107 STONE CLIFF ROAD, PRINCETON NJ 08540
Betsy D Holden director DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Kathy Widmer officer: Group President, NALA C/O ELIZABETH ARDEN, INC., 2400 S.W. 145 AVENUE, MIRAMAR FL 33027
Michael E Sneed director JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Joseph J Wolk director JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933

Kenvue (Kenvue) Headlines

From GuruFocus